275 results on '"Zaratin, Paola"'
Search Results
2. Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
3. The MULTI-ACT model: the path forward for participatory and anticipatory governance in health research and care
4. Collective health research assessment: developing a tool to measure the impact of multistakeholder research initiatives
5. The first global landscape analysis of multiple sclerosis research funding.
6. An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases
7. Brain activity pattern changes after adaptive working memory training in multiple sclerosis
8. User testing as a method for evaluating subjects’ understanding of informed consent in clinical trials in multiple sclerosis
9. Steps towards Collective Sustainability in Biomedical Research
10. Measuring outcomes that matter most to people with multiple sclerosis: the role of patient-reported outcomes
11. The Italian multiple sclerosis register
12. Assessing the health research’s social impact: a systematic review
13. A Systematic Review of Patient Engagement Experiences in Brain Disorders
14. Multiple sclerosis and rehabilitation: an overview of the different rehabilitation settings
15. Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-Job): definition of the cut-off score
16. The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions
17. A Systematic Review of Patient Engagement Experiences in Brain Disorders
18. Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal
19. Workers with disability: the case of multiple sclerosis
20. Economic impact of multiple sclerosis in Italy: focus on rehabilitation costs
21. Correction to: The Italian multiple sclerosis register
22. Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance
23. Additional file 1 of Collective health research assessment: developing a tool to measure the impact of multistakeholder research initiatives
24. Additional file 2 of Collective health research assessment: developing a tool to measure the impact of multistakeholder research initiatives
25. Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal
26. Collective health research assessment: Development of a tool to measure the impact of multi-stakeholder research initiatives
27. Atrophy quantification in multiple sclerosis: Application to the multicenter INNI dataset
28. Evaluation woes: define metrics from the off
29. Predominant cognitive phenotypes in multiple sclerosis: Insights from patient-centered outcomes
30. Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal
31. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties
32. Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barrè syndrome
33. Impact of Multiple Sclerosis on Cognitive Aging: A Multicenter Study (2556)
34. Different disease modifying therapies can increase or decrease Covid-19 severity in Multiple Sclerosis (2021)
35. Impact of the COVID-19 pandemic on persons with multiple sclerosis: Early findings from a survey on disruptions in care and self-reported outcomes
36. Pharmacologic P2X Purinergic Receptor Antagonism in the Treatment of Collagen-Induced Arthritis
37. Predictors of clinically significant anxiety in people with multiple sclerosis: A one-year follow-up study
38. Disease Modifying Therapies and COVID-19 Severity in Multiple Sclerosis
39. An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases
40. A novel role for receptor like protein tyrosine phosphatase zeta in modulation of sensorimotor responses to noxious stimuli: Evidences from knockout mice studies
41. The Multiple Sclerosis Care Unit
42. Motor evoked potentials in a mouse model of chronic multiple sclerosis
43. Schwann cell overexpression of the GPR7 receptor in inflammatory and painful neuropathies
44. The Italian multiple sclerosis register
45. The Multiple Sclerosis Care Unit
46. Impact of the COVID-19 pandemic on persons with multiple sclerosis: Early findings from a survey on disruptions in care and self-reported outcomes.
47. Evaluation woes. Start right
48. Integration and Characterization of Brain MRI Data from the Italian Neuroimaging Network Initiative (INNI) for the Study of Multiple Sclerosis (P5.2-034)
49. Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation
50. Knockout mice reveal a role for protein tyrosine phosphatase H1 in cognition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.